Data too important to share: Do those who control the data control the message?

BMJ (Online)

Volumn 352, Issue , 2016, Pages

  Doshi, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ACCESS TO INFORMATION; ADVERSE OUTCOME; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL (TOPIC); CRYSTALLOID; DATA ANALYSIS; EUROPE; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; FLUID RESUSCITATION; HUMAN; MEDICAL INFORMATION; MORTALITY; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; PUBLICATION; REFUSAL TO PARTICIPATE; RISK FACTOR; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; CLINICAL TRIAL (TOPIC); ELECTRONIC HEALTH RECORD; GREAT BRITAIN; PERSONNEL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RESUSCITATION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ACCESS TO INFORMATION; ACUTE KIDNEY INJURY; CLINICAL TRIALS AS TOPIC; ELECTRONIC HEALTH RECORDS; GREAT BRITAIN; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PLASMA SUBSTITUTES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; RESEARCH PERSONNEL; RESUSCITATION; UNITED STATES;

EID: 84960357146     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i1027     Document Type: Note

References (19)

1. Thomas K. Johnson & Johnson will make clinical data available to outside researchers. New York Times 2015 Jan 14. www.nytimes.com/2015/01/15/business/johnson-johnsonto-make-clinical-data-available-to-outside-researchers.html
2. Krumholz HM, Ross JS, Gross CP, et al. A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med 2013;158:910-1. doi:10.7326/0003-4819-158-12-201306180-00009. 23778908.
3. Doshi P, Vedula SS, Li T. YODA and truth seeking in medicine. BMJ 2013;347:f4251.23819966.
4. Crystalloid versus hydroxyethyl starch trials (CHEST). https://clinicaltrials.gov/show/NCT00935168
5. Myburgh JA, Finfer S, Bellomo R, et al. CHEST Investigators Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11. doi:10.1056/NEJMoa1209759. 23075127.
6. FDA. FDA safety communication: boxed warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings. 2013. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm358271.htm.
7. EMA. PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl starch. 2013. www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2013/06/news-detail-001814.jsp&mid=WC0b01ac058004d5c1.
8. Medicines and Healthcare Products Regulatory Agency. Hydroxyethyl starch (HES) products - increased risk of renal dysfunction and mortality. 2013. https://www.gov.uk/drug-device-alerts/drug-alert-hydroxyethyl-starch-hes-products-increased-risk-of-renaldysfunction-and-mortality.
9. Priebe H-J. Methodological issues of the studies cited. Dtsch Arztebl Int 2013;110:735.24222798.
10. Drazen JM. Believe the data. N Engl J Med 2012;367:1152-3. doi:10.1056/NEJMe1207121. 22992081.
11. Myburgh JA. Fraud in fluid resuscitation research. Med J Aust 2011;194:621-2.21692716.
12. Perner A, Haase N, Guttormsen AB, et al. 6S Trial Group Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34. PubMed doi:10.1056/NEJMoa1204242.22738085.
13. Al-Khafaji A, Webb AR. Fluid resuscitation. Contin Educ Anaesth Crit Care Pain. 2004;4:127-31doi:10.1093/bjaceaccp/mkh031.
14. Twigley AJ, Hillman KM. The end of the crystalloid era? A new approach to peri-operative fluid administration. Anaesthesia 1985;40:860-71. doi:10.1111/j.1365-2044.1985.tb11047. x. 3901814.
15. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998;316:961-4. doi:10.1136/bmj.316.7136.961. 9550953.
16. Finfer S, Liu B, Taylor C, et al. SAFE TRIPS Investigators. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010;14:R185. doi:10.1186/cc9293. 20950434.
17. Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med 2011;37:816-23. doi:10.1007/s00134-010-2117-9. 21308360.
18. Finfer S, Bellomo R, Boyce N, et al. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56. doi:10.1056/NEJMoa040232. 15163774.
19. Wise J. Boldt: the great pretender. BMJ 2013;346:f1738.23512099.